The UK is seeing a growing interest in mind-altering compounds , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Investigators are increasingly exploring the possibilities of these chemicals for mental health purposes, prompting a nuanced discussion around their legal stand